ArticleDrug delivery2017

Anti-CD123 antibody-modified niosomes for targeted delivery of daunorubicin against acute myeloid leukemia.

Fu-Rong Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.